An Aggressive Case Of Infundibulocystic Squamous Cell Carcinoma On The Upper Lip: A Hybrid Pathology Of Well-Differentiated And Infiltrative Variants
Keywords:
squamous cell carcinoma, follicular differentiation, immunohistochemistry , chemoradiation therapy dermoscopyReferences
Kossard S, Tan KB, Choy C. Keratoacanthoma and infundibulocystic squamous cell carcinoma. Am J Dermatopathol. 2008; 30: 127-34.
Misago N, Inoue T, Toda S, Narisawa Y. Infundibular (Follicular) and Infundibulocystic Squamous Cell Carcinoma: A Clinicopathological and Immunohistochemical Study. Am J Dermatopathol. 2011; 33: 687-94.
Vasiljevic N, Andersson K, Bjelkenkrantz K et al. The Bcl-xL inhibitor of apoptosis is preferentially expressed in cutaneous squamous cell carcinoma compared with that in keratoacanthoma. Int J Cancer. 2009; 124: 2361-2366.
Kim SM, Kim H, Kim HS, Cho SH, Lee JD. Infundibulocystic Squamous Cell Carcinoma. Ann Dermatol. 2015; 27: 319-321.
Suma A, Ando Y, Yahata Y. A case of infundibulocystic squamous cell carcinoma, initially made a diagnosis of milia en plaque. Skin Cancer. 2015; 30: 1-5.
Kossard S. Keratoacanthoma, committed stem cells and neoplastic aberrant infundibulogenesis integral to formulating a conceptual model for an infundibulocystic pathway to squamous cell carcinoma. J Cutan Pathol. 2021; 48: 184-91.
Published
Issue
Section
License
Copyright (c) 2023 Takumi Hasegawa, Shiro Iino, Shiori Sekine, Kohei Kitakaze, Natsuki Baba, Noritaka Oyama, Minoru Hasegawa

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.

